The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer, the health regulator's ...

The FDA has approved Astellas' Vyloy to treat gastric cancer. Egypt has been certified malaria-free by WHO. A Tennessee court ...

After a prior rejection, Astellas can head into the weekend celebrating a class-first FDA approval for its new gastric cancer ...

In Germany, around 17,000 people are diagnosed with gastric cancer every year. The disease is one of the leading causes of ...

Zolbetuximab — now with the brand name Vyloy — is a monoclonal antibody to treat patients with advanced gastric and ...

Astellas Pharma today announced that the US Food and Drug Administration (FDA) has approved VYLOY (zolbetuximab-clzb) in ...

Conversion surgery is becoming a viable option for patients with metastatic gastric cancer who respond well to induction ...

FDA also approved the Ventana CLDN18 (43-14A) RxDx Assay, from Ventana Medical Systems, Inc. and Roche Diagnostics, to ...

Former Communication Authority of Kenya employee, Mathew Nyamlori who was diagnosed with stage 3 gastric cancer in 2023 seeks ...

In Germany, around 17,000 people are diagnosed with gastric cancer every year. The disease is one of the leading causes of ...

The FDA approved Astellas' gastric cancer therapy. CVS Health CEO Karen Lynch steps down amid shareholder pressure, with ...

In Germany, around 17,000 people are diagnosed with gastric cancer every year. The disease is one of the leading causes of ...